特发性脉络膜新生血管疾病是一种会严重影响患者视力的疾病，目前临床主要采用光动力疗法对患者进行治疗，随着研究的不断深入，治疗方法也在不断完善，治疗效果得到强化。光动力疗法在临床上的应用已经长达10年，虽然其有着一定的局限性，但在脉络膜新生血管治疗中的效果已经得到广泛认可，成为不可替代的治疗手段，并且相关研究正在不断深入，以期降低脉络膜新生血管的复发率，提高其经济性的同时更好地抑制患者的病变发展，延长疾病的控制时间。该文首先分析了光动力疗法治疗特发性脉络膜新生血管的作用机理以及光动力疗法治疗脉络膜新生血管临床疗效的认可情况，然后阐述了光动力疗法治疗脉络膜新生血管的临床进展。%Idiopathic choroidal neovascularization is a kind of disease will seriously affect the patient acuity of illness, at present the main clinical use for the treatment of patients with photodynamic therapy, with the deepening of the study, treatment methods are constantly improving, the treatment effect is strengthened. Photodynamic therapy in clinical application has been for ten years, although it has certain limitation, but in the treatment for choroidal neovascularization in the treatment effects have been widely recognized, has become an irreplaceable means of treatment, and the related research is unceasingly thorough, in order to reduce the recurrence rate of choroidal neovascularization, to improve the economy and better can inhibit the development of lesions in patients with prolonged disease, control. This paper first analyzes the recognition mechanism of neovascularization and photody-namic therapy for choroidal photodynamic therapy for the treatment of idiopathic choroidal neovascularization clinical efficacy, and then describes the clinical development of photodynamic therapy for choroidal neovascularization.
展开▼
